AstraZeneca Says Third Dose Of Its Vaccine Raises Omicron Antibodies “Significantly”

December 23, 2021

The pharmaceutical laboratory AstraZeneca said Thursday that a third dose of its vaccine against covid-19 “significantly” increases the level of antibodies against the omicron variant, citing a clinical study.

“The levels of antibodies that neutralize omicron after a third dose” of the AstraZeneca anticovid vaccine, “were globally similar to the levels reached after two doses against the delta variant,” the statement details.

at / mar / zm